Ifty Saiyed serves as the co-Chief Executive Officer and co-founder of RApport Global Scientific Services, headquartered in London. In addition to his leadership role at RApport, Ifty holds a position on the Board of Directors at ELIQUENT Life-sciences. Ifty leads the charge in steering the development and delivery of innovative regulatory healthcare solutions, while also charting an ambitious and visionary roadmap for the Company.
Bringing over two decades of experience to the life sciences industry, Ifty is a seasoned global regulatory leader with a robust background in multinational pharmaceutical companies, contract research organisations, and regulatory agencies across diverse regions such as ICH, LATAM, and MENA. His expertise lies in providing strategic regulatory solutions that align seamlessly with overarching business objectives, supporting leadership teams, and navigating complex regulatory landscapes.
Ifty demonstrates exceptional expertise in navigating strategic clinical and regulatory hurdles within the field of biologicals. He excels in cultivating team capabilities, promoting collaboration across project teams and external entities, guiding work streams, adeptly handling technical writing, and successfully managing global due diligence projects with assurance. In his role as a highly proficient business development professional, he excels in comprehending client requirements and identifying optimal solutions,
An advocate for regulatory intelligence and policy, Ifty actively contributes to driving projects forward by leveraging technology, specifically emphasising the role of data science and intelligent automation in accelerating progress in healthcare. He champions the use of these tools for insight generation and underscores their ability to unite teams with expertise and purpose to tackle the most formidable health issues globally.
Ifty’s extensive international experience enriches his global perspective and understanding of diversity in all its forms. Committed to fostering an inclusive workforce at RApport, he aims to create a team that reflects the diversity of the patient population the company serves.
Beyond his role at RApport, he also contributes to academia at Kingston University, where he imparts knowledge on Regulatory Affairs. Within RApport, Ifty assumes the role of the primary client contact, finding particular enjoyment in the development of fully integrated CMC development, overseeing international expansion of regulatory strategies, and leveraging AI-driven methodologies to optimise processes and enhance overall operational efficiency.